Evaluating Metagenomic Prediction of the Metaproteome in a 4.5-Year Study of a Patient with Crohn's Disease

DOI: 10.1128/mSystems.00337-18

Article Information

DOI

Published By

History

Editors and / or Reviewers

^aDepartment of Pharmacology, University of California, San Diego, San Diego, California, USA
^bSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, San Diego, California, USA
^cDepartment of Pediatrics, and Department of Computer Science and Engineering, University of California, San Diego, San Diego, California, USA
^dDepartment of Family Medicine and Public Health, University of California, San Diego, San Diego, California, USA
^eDepartment of Computer Science and Engineering, University of California, San Diego, San Diego, California, USA
^fCalifornia Institute for Telecommunications and Information Technology, University of California, San Diego, San Diego, California, USA
^gCenter for Microbiome Innovation, University of California, San Diego, San Diego, California, USA

Address correspondence to Rob Knight, robknight{at}ucsd.edu, or David J. Gonzalez, djgonzalez{at}ucsd.edu.
Citation Mills RH, Vázquez-Baeza Y, Zhu Q, Jiang L, Gaffney J, Humphrey G, Smarr L, Knight R, Gonzalez DJ. 2019. Evaluating metagenomic prediction of the metaproteome in a 4.5-year study of a patient with Crohn's disease. mSystems 4:e00337-18. https://doi.org/10.1128/mSystems.00337-18.